ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective

Published:2014-06-26 Issue: Volume:20 Page:17-26
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Oldenburg J.¹,Austin S. K.²,Kessler C. M.³

Affiliation:

1. Institute for Experimental Haematology and Transfusion Medicine; University Clinic Bonn; Bonn Germany

2. St. George's Healthcare NHS Trust Haemophilia Centre; St. George's Hospital; London UK

3. Hemophilia and Thrombophilia Comprehensive Care Center; Georgetown University Hospital; Washington DC USA

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12466/fullpdf

Reference59 articles.

1. Immune tolerance for the treatment of factor VIII inhibitors-twenty years ‘Bonn protocol’;Brackmann;Vox Sang,1996

2. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII;Nilsson;N Engl J Med,1988

3. Tolerance induction using the Malmö treatment model 1982-1995;Freiburghaus;Haemophilia,1999

4. Low-dose immune tolerance induction in hemophilia A patients with inhibitors;Mauser-Bunschoten;Blood,1995

5. Recovery from anti-VIII: C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII: C autoantibodies;Sultan;Proc Natl Acad Sci USA,1987

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors;Journal of Thrombosis and Haemostasis;2023-06

2. Emicizumab for All Pediatric Patients with Severe Hemophilia A;Hämostaseologie;2022-04

3. Outcomes in children with hemophilia A with inhibitors: Results from a noninterventional study;Pediatric Blood & Cancer;2020-08-09

4. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges;Hämostaseologie;2020-07-29

5. Efectividad de inducción de tolerancia inmune en niños con hemofilia A y aloanticuerpos neutralizantes;Revista Chilena de Pediatría;2020-04-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3